The only likely PR this week that come to mind are BLA or enrollment updates. I would love to hear we are approaching 75 by the weekend, but the figures last week were light.
Let's be real, we aren't getting approval in UK while we are starting a trial for the US FDA. The cancer enrollment/BTD meeting are going to be slow to materialize in the COVID world.
Market Data 
Markets 
AI
